MACSF

COMMUNIQUÉS West-GlobeNewswire

AVITA Medical to Announce Second Quarter 2025 Financial Results
28/07/2025
VALENCIA, Calif. and MELBOURNE, Australia, July 28, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today [...]
iMDx to Host Virtual KOL Event to Discuss its In-House dd-cfDNA Testing for Kidney Transplant Patients on August 15, 2025
28/07/2025
NASHVILLE, Tenn., July 28, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics, or iMDx, (Nasdaq: IMDX), today announced that it will host a virtual key opinion leader (KOL) event on Friday, August 15, 2025 at 4:00 [...]
Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
28/07/2025
- Expected cash runway extended into Q3 2027, beyond multiple potential inflection points including Dyne’s first planned commercial launch in early 2027 - - Registrational Expansion Cohort of DELIVER Trial of DYNE-251 [...]
Abivax Announces Closing of $747.5 Million Public Offering
28/07/2025
Abivax Announces Closing of $747.5 Million Public Offering PARIS, France, July 28, 2025 – 10:15 p.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“ Abivax ” or the “ Company ”), a clinical-stage [...]
Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
28/07/2025
Informations Réglementées Châtillon, France, le 28 juillet (22 h 30 CET) 2025 Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq : [...]
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
28/07/2025
AMF Regulated Information Châtillon, France, July 28, 2025 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a [...]
Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering
28/07/2025
WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects the version issued on July 24, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is [...]
Cellectis publiera ses résultats financiers du deuxième trimestre 2025 le 4 août 2025
28/07/2025
NEW YORK, 28 juill. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS) (la « Société »), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome [...]
Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025
28/07/2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell [...]
Tilray Brands Reports Fourth Quarter and Fiscal 2025 Financial Results
28/07/2025
Fiscal Year Net Revenue of $821 Million, $834 Million in Constant Currency, Strategic Decisions Impacted Revenue by $35 Million Q4 Consolidated Adjusted EBITDA is the 2 nd Highest in the Company’s History International [...]
Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering
28/07/2025
WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects a version issued on July 25, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not [...]
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
28/07/2025
SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its [...]
Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status
28/07/2025
CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) received two different communications from the staff of the Nasdaq Listing Qualifications office of the [...]
Tevogen.AI Applauds U.S. Government’s AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare
28/07/2025
WARREN, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today welcomes the White House’s release of “Winning the Race: America’s AI Action Plan”, issued July [...]
Press release: Transparency Notification from Shareholders
28/07/2025
Transparency Notification from Shareholders Ghent, Belgium – 28 July 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of drug-resistant fluid [...]
EssilorLuxottica: Résultats T2/S1 2025 - Solide croissance du chiffre d'affaires à 7,3 % au T2 et au S1, nouvelle accélération sur les lunettes avec IA
28/07/2025
Solide croissance du chiffre d'affaires à 7,3 % au T2 et au S1 Nouvelle accélération sur les lunettes avec IA Croissance du chiffre d'affaires du Groupe à 7,3 % au T2 et au S1 (à taux de change constants 1 ) L'Amérique [...]
EssilorLuxottica: Q2/H1 2025 Results - Sound revenue growth at 7.3% in Q2 and H1, AI glasses speeding up further
28/07/2025
Sound revenue growth at 7.3% in Q2 and H1 AI glasses speeding up further Group’s revenue growing 7.3% in both Q2 and H1 (constant exchange rates 1 ) North America accelerating in PS, DTC keeping a solid growth pace EMEA [...]
Floe Health Launches to Power Intelligence at Every Patient Touchpoint
28/07/2025
San Francisco, CA, July 28, 2025 (GLOBE NEWSWIRE) -- Floe Health , a new Healthcare AI company focused on solving the hidden operational gaps in healthcare, today announced the official launch of its platform built to [...]
Can-Fite Announces Up To $15.0 Million Public Offering
28/07/2025
$5.0 million upfront with up to an additional $10.0 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants RAMAT GAN, Israel, July 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma [...]

Pages